You have 9 free searches left this month | for more free features.

PDGFRA

Showing 1 - 25 of 102

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • +2 more
    • (no location specified)
    Jul 15, 2022

    Solid Tumor, Unspecified, Child, Relapsed Solid Tumor, CNS Tumor Trial in Worldwide (avapritinib)

    Recruiting
    • Solid Tumor, Unspecified, Child
    • +2 more
    • Phoenix, Arizona
    • +12 more
    Jul 19, 2022

    GIST, GIST, Malignant, PDGFR-Alpha D842V Trial in France (Patient treated by Avapritinib in real life)

    Recruiting
    • GIST
    • +2 more
    • Patient treated by Avapritinib in real life
    • Besançon, France
    • +5 more
    Jun 9, 2021

    Recurrent/Refractory Glioblastoma Trial in Houston (crenolanib)

    Completed
    • Recurrent/Refractory Glioblastoma
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 17, 2020

    FLT3-ITD Mutation, FLT3/TKD Mutation, PDGFR-Alpha D842V Trial in Genova (Crenolanib besylate)

    Available
    • FLT3-ITD Mutation
    • +3 more
    • Crenolanib besylate
    • Genova, Italy
      Ospedale Policlinico San Martino
    May 21, 2020

    GIST With D842V Mutated PDGFRA Gene Trial in Worldwide (Crenolanib, Placebo)

    Active, not recruiting
    • GIST With D842V Mutated PDGFRA Gene
    • Santa Monica, California
    • +22 more
    Jan 21, 2021

    Oncogenetic Panel and Integrated Clinical Data Registry Study

    Recruiting
    • Gastrointestinal Stromal Tumor (GIST)
      • Changhua, Taiwan
      • +12 more
      Dec 6, 2022

      Meta-analysis of Metatrascryptome and Transcriptome of

      Not yet recruiting
      • Eosinophilic Esophagitis
      • Formalin-fixed Paraffin-embedded (FFPE) tissue samples analysis
      • Milan, Italy
        IRCCS Ospedale San Raffaele
      Oct 2, 2023

      Malignant Tumor Trial in Ann Arbor, Columbus (ponatinib HCl, laboratory biomarker analysis)

      Unknown status
      • Malignant Neoplasm
      • ponatinib hydrochloride
      • laboratory biomarker analysis
      • Ann Arbor, Michigan
      • +1 more
      Feb 14, 2020

      Avapritinib in Chinese Gastrointestinal Stromal Tumor in Real

      Recruiting
      • Gastrointestinal Stromal Tumors
      • Avapritinib
      • Tyrosine kinase inhibitors other than avapritinib ( imatinib, sunitinib, et al )
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Sep 14, 2022

      Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

      Recruiting
      • Core Binding Factor Acute Myeloid Leukemia
      • KIT Mutation-Related Tumors
      • Suzhou, Jiangsu, China
        First Affiliated Hospital of Soochow University
      Apr 7, 2023

      Metastatic or Unresectable Gastrointestinal Stromal Tumors

      Not yet recruiting
      • Gastrointestinal Stromal Tumors
      • +2 more
        • (no location specified)
        Jul 16, 2022

        Surgery in Gastrointestinal Stromal Tumors for Treatment, Tumor

        Recruiting
        • Gastric Cancer
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 30, 2023

          Gastrointestinal Stromal Tumor (GIST) Trial in Guayaquil (Endoscopic ultrasound guided radiofrequency ablation)

          Recruiting
          • Gastrointestinal Stromal Tumor (GIST)
          • Endoscopic ultrasound guided radiofrequency ablation
          • Guayaquil, Guayas, Ecuador
            Instituto Ecuatoriano de Enfermedades Digestivas (IECED)
          Aug 8, 2022

          Glioblastoma, Recurrent Adult Brain Tumor, Malignant Glioma Trial in Richmond (sorafenib tosylate, valproic acid, sildenafil

          Active, not recruiting
          • Glioblastoma
          • +3 more
          • sorafenib tosylate
          • +2 more
          • Richmond, Virginia
            Virginia Commonwealth University/Massey Cancer Center
          Mar 21, 2022

          Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

          Recruiting
          • Lymphoma, Non-Hodgkin
          • +2 more
          • Edmonton, Alberta, Canada
          • +9 more
          Jan 9, 2023

          Gastrointestinal Stromal Tumors Trial in Seoul (Temozolomide capsule)

          Not yet recruiting
          • Gastrointestinal Stromal Tumors
          • Temozolomide capsule
          • Seoul, Korea, Republic of
            Asan Medical Center, University of Ulsan College of Medicine
          Dec 14, 2022

          GIST: Assessment of Tumor Mutations and TKI Plasma Exposure

          Recruiting
          • Gastro-intestinal Stromal Tumor
          • Vena puncture for blood collection
          • Tumor biopsy
          • Amsterdam, Netherlands
          • +4 more
          May 17, 2022

          Gastrointestinal Stromal Tumors (GIST), Other Relapsed or Refractory Solid Tumors Trial in Worldwide (Avapritinib)

          Completed
          • Gastrointestinal Stromal Tumors (GIST)
          • Other Relapsed or Refractory Solid Tumors
          • Scottsdale, Arizona
          • +18 more
          May 20, 2022

          ctDNA in Cancer Early Detection and STAS Evaluation in GGOs

          Not yet recruiting
          • Lung Cancer
          • +2 more
          • cf DNA and ct DNA
          • Roma, Italy
            Thoracic Surgery Unit, Sapienza University of Rome
          Mar 31, 2022

          Integrated Molecular Profiling in Advanced Cancers Trial

          Active, not recruiting
          • Breast Cancer
          • +9 more
            • Toronto, Ontario, Canada
              Princess Margaret Hospital
            Sep 26, 2022

            Ripretinib Combined With Surgery in Advanced GIST That Have

            Recruiting
            • Gastrointestinal Stromal Tumor(GIST)
            • Resection surgery of gastrointestinal stromal tumor
            • Chengdu, Sichuan, China
              Sichuan Provincial People's Hospital
            Apr 25, 2022

            Gastrointestinal Stromal Tumors Trial (Imatinib Mesylate)

            Recruiting
            • Gastrointestinal Stromal Tumors
            • Imatinib Mesylate
            • Seoul, Korea, Republic of
              Asan Medical Center, University of Ulsan College of Medicine
            Dec 22, 2022

            Malignant Solid Tumors Trial in France (Nilotinib (400 mg BID), Everolimus (10 mg QD), Sorafenib (400 mg BID))

            Recruiting
            • Malignant Solid Neoplasms
            • Nilotinib (400 mg BID)
            • +6 more
            • Bordeaux, France
            • +6 more
            Dec 15, 2022

            Second-line Pharmacotherapy Patterns and Outcomes of Advanced

            Not yet recruiting
            • Gastrointestinal Stromal Tumors
              • Guangzhou, Guangdong, China
                The first affiliated hospital,Sun yat-sen university
              Jun 30, 2022